SMEs can apply for a share of up to £8 million to continue a project’s early stage development and technical evaluation, up to readiness for clinical testing.
Programme: Innovate UK
Award: Up to £8m
Opens: 26th Mar 2018
Closes: 6th Jun 2018
The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to):
The aim of the early stage award is to create a data package that is sufficient to support the subsequent testing of your products or process in a clinical setting or other relevant environment. It can include:
Innovate UK expect projects to start from a point where their technology has been validated in a laboratory or relevant setting and finish at a point where the technology has been demonstrated in a relevant environment (but excluding any human clinical trials).
Support is available for any sector or discipline, including (but not limited to):
To lead a project you must:
For all research organisations, the maximum level of project participation is 50% of total eligible project costs. If your consortium contains more than one research organisation, they must share this allocation
Innovate UK expect the total project costs to range in size from £250,000 to £4 million. Projects should last between 12 and 36 months. Successful applicants will be notified of their start date by Innovate UK.
You could get funding for your eligible project costs of: